EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metformin use in pregnancy: What about long‐term effects in offspring?

Johanne Holm Toft iD, Inger Økland iD

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Johanne Holm Toft und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Stavanger University Hospital, Stavanger, Norway. Hauptthemen laut MEDLINE: Metformin, Hypoglycemic Agents, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin use in pregnancy is increasing worldwide. Unlike insulin, metformin crosses the placenta. Consequently, maternal and fetal concentrations are comparable. Teratogenic effects are not reported, nor are adverse pregnancy outcomes. Reduced risk of hypertensive disorders, hypoglycemia, and macrosomia are potential benefits, together with lower gestational weight gain. Although metformin has been prescribed for pregnant women during the last 40 years, long‐term data regarding offspring outcomes are still lacking. Independent of maternal glycemic control, recent meta‐analyses report lower birthweight but accelerated postnatal growth and higher body mass index in metformin‐exposed children. The longest follow‐up study of placebo‐controlled metformin exposure in utero found an increased prevalence of central adiposity and obesity among children 5–10 years old. Recently, a Danish study reported a threefold increased risk of genital anomalies in boys, whose fathers used metformin around the time of conception. This commentary addresses the current controversies on metformin use in pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminHypoglycemic AgentsPrenatal Exposure Delayed EffectsHumansPregnancyFemaleMalePregnancy OutcomeDiabetes, GestationalInfant, Newborn

Stichwörter der Autor:innen

gestational diabetesmaternal exposuremetforminpolycystic ovary syndromepregnancy outcometype 2 diabetes

Substanzen

MetforminHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Stavanger University Hospital, Stavanger, Norway.
  • Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Department of Caring and Ethics, University of Stavanger, Stavanger, Norway.

ORCID-Profile: Johanne Holm Toft, Inger Økland

Zitieren

APA

Toft, J. H., & Økland, I. (2024). Metformin use in pregnancy: What about long‐term effects in offspring?. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14878

Vancouver

Toft JH, Økland I. Metformin use in pregnancy: What about long‐term effects in offspring?. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14878

BibTeX
@article{Toft2024,
  author = {Toft, Johanne Holm and Økland, Inger},
  title = {Metformin use in pregnancy: What about long‐term effects in offspring?},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14878}
}
Kostenlos starten →